de la Riviere A B, Defauw J J, Knaepen P J, van Swieten H A, Vanderschueren R C, van den Bosch J M
Department of Thoracic Surgery, St Antonius Hospital, Nieuwegein, The Netherlands.
Ann Thorac Surg. 1997 Oct;64(4):954-7; discussion 958-9. doi: 10.1016/s0003-4975(97)00797-2.
Bronchopeural fistula after pneumonectomy, with associated empyema, has no standard therapy. The transsternal, transpericardial approach was used in all patients presenting with a large fistula.
From 1974 through 1995, 55 patients underwent transsternal, transpericardial closure of a bronchopleural fistula. Mean age was 62.7 years (range, 33 to 78 years). Malignant disease had been the indication for pneumonectomy in 50 patients and benign lesions in 5 patients. The fistula was right-sided in 41 patients (74.5%), and the bronchial stump was less than 2 cm in 25 (45.5%). Treatment of the concomitant empyema was by closed drainage in 2 patients, by repeated needle aspiration in 17, and by open thoracostomy in 36 patients. Reamputation and closure of the stump was possible in 51 patients; in 4 a primary carinal resection was done.
Three patients died within 30 days after operation (5.4%, 70% confidence interval 2.4%-10.7%). Ten patients died late during hospitalization, total hospital mortality, 23.6% (70% confidence interval 17.3% to 31.0%). Recurrent fistula symptoms were caused by a large recurrency in 6 patients (all died), by a small one in 7 (one death due to pulmonary embolism). Mean duration of hospital stay was 56 days (range, 2 to 174 days). At follow-up of 42 patients, there were no recurrent fistulas. All patients with benign lesions are alive and well. Of 37 cancer patients, 29 died, more than half due to malignancy. Risk factors for death included recurrent fistula, short interval between pneumonectomy and onset of fistula, and closing technique. Risk factors for recurrent fistula were a short bronchial stump and the nonuse of an open thoracostomy.
Long-term results of transsternal closure are good, but hospital mortality is high. The present treatment of patients with large postpneumonectomy bronchopleural fistula includes early open thoracostomy, improvement of nutritional status, transsternal closure using resorbable sutures, and closure of the pleural space 3 weeks later.
肺切除术后支气管胸膜瘘合并脓胸尚无标准治疗方法。所有出现大瘘口的患者均采用经胸骨、经心包入路。
1974年至1995年,55例患者接受了经胸骨、经心包闭合支气管胸膜瘘手术。平均年龄62.7岁(范围33至78岁)。50例患者因恶性疾病行肺切除术,5例因良性病变行肺切除术。41例患者(74.5%)瘘口在右侧,25例(45.5%)支气管残端小于2cm。2例合并脓胸患者采用闭式引流治疗,17例采用反复针吸治疗,36例采用开胸造口术治疗。51例患者可行残端再切除和闭合;4例患者行一期隆突切除。
3例患者术后30天内死亡(5.4%,95%可信区间2.4%-10.7%)。10例患者住院期间晚期死亡,总住院死亡率为23.6%(95%可信区间17.3%至31.0%)。6例患者因大复发导致瘘复发症状(均死亡),7例因小复发导致瘘复发症状(1例因肺栓塞死亡)。平均住院时间为56天(范围2至174天)。42例患者随访时无瘘复发。所有良性病变患者均存活且情况良好。37例癌症患者中,29例死亡,一半以上死于恶性肿瘤。死亡的危险因素包括瘘复发、肺切除术后至瘘发生的间隔时间短以及闭合技术。瘘复发危险因素为支气管残端短和未采用开胸造口术。
经胸骨闭合术的长期效果良好,但住院死亡率高。目前对肺切除术后大支气管胸膜瘘患者的治疗包括早期开胸造口术、改善营养状况、使用可吸收缝线经胸骨闭合以及3周后闭合胸膜腔。